Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: No intervention will be given to patients..
- Who it may be relevant to
- Registry conditions: Colorectal Cancer, Gastric Cancer, Inflammatory Bowel Diseases, Gastric Ulcer. Basic parameters: 18 years — 80 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Samples Procurement for Patients With Colorectal Cancer, Gastric Cancer, and Non-malignant Disease Undergoing Surgery
Overview
The purposes of this study are to collect and store samples including blood, normal and tumor tissue from patients with colorectal cancer or gastric cancer, to collect and store samples including blood and/or normal gastrointestinal tissue (if available) from patients with non-malignant disease (including, but not limited to, inflammatory bowel disease (IBD), gastric ulcer, hemorrhoids or hernia), and to create a database for the collected samples and allow access to relevant clinical information for current and future protocols.
Interventions
- Other No intervention will be given to patients.
Samples are collected at the time of a scheduled surgery that is part of normal treatment. This study will not have any impact on the care or treatment the patient receives.
Primary outcome measures
- Confirmation of diagnosis by pathologist [Time frame: Up to 3 years]
Eligibility criteria
Inclusion criteria
- Any patient diagnosed with colorectal cancer, gastric cancer, non-malignant disease that requires undergoing surgery.
- Must be willing and able to provide informed consent.
Exclusion criteria
- Subjects whose comorbidities would preclude diagnostic or therapeutic intervention.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Case-only
Study locations
China · 1 center
- Department of Gastrointestinal Surgery II, Renmin Hospital of Wuhan University — Wuhan
Identifiers
NCT: NCT03972956 · SAMPGICUS